Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)
N/A
To evaluate whether the combination of clinicopathological factors and the ...
Status
Recruiting
Location
Arthur J.E. Child Comprehensive Cancer Centre
Start Date
2022-11-23
Trial ID
NCT04797299
Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer
N/A
Oncotype DX® is likely to become more widely used in Europe as well as in S...
Status
Completed
Location
Kantonsspital Baden
Start Date
2013-09
Trial ID
NCT01926964
Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS
N/A
To evaluate whether the use of the Oncotype DX DCIS score can guide deliver...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2016-08
Trial ID
NCT02766881
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
PHASE3
This phase III trial compares standard of care hormone therapy plus ribocic...
Status
Recruiting
Location
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro